Goldstein Dov A Md - 28 Dec 2022 Form 3 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
28 Dec 2022
Transactions value $
$0
Form type
3
Filing time
28 Dec 2022, 19:38:13
Previous filing
22 Sep 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding COYA Stock Option (right to buy) 28 Dec 2022 Common Stock, par value $0.0001 per share 17.6K $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in 36 equal monthly installments commencing on April 1, 2021.
F2 The shares reported reflect the 1 for 5.6955 stock split effected December 12, 2022.

Remarks:

Exhibit 24--Power of Attorney